HF 1183 (see companion bill SF 1265) – Minnesota

Status: In Process
Year Introduced: 2021
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF1183&ssn=0&y=2021

Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found